# Vitamin D in Fatty Liver Disease

> **NCT04038853** · PHASE4 · COMPLETED · sponsor: **University Hospital Rijeka** · enrollment: 360 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease
- Vitamin D Deficiency

## Interventions

- **DRUG:** 1,25-Dihydroxyvitamin D
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04038853
- **Lead sponsor:** University Hospital Rijeka
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-01
- **Primary completion:** 2017-02-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2019-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04038853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04038853, "Vitamin D in Fatty Liver Disease". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04038853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*